MSB 2.10% $1.17 mesoblast limited

Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-205

  1. 7,518 Posts.
    lightbulb Created with Sketch. 6772
    DocMcStuffins is positively mild on the HC barometer. His last post in his defence was vaguely informative. Nothing wrong with a bit of objective debate, just as long as its well balanced and accurate. His initial comments clearly were not fairly representative and subsequent arguments weak as @Phaedrus has shown. But on the flip side we are a little more informed for once again some excellent insight on MSB.

    I've personally been stalked on another stem cell company thread (my largest long investment above MSB) because I posted a few valuation posts on an 'APT valuation' thread. It was as if I'd killed their first born. Let's never get like that in here.

    I have to say you get a few idiots, but for the most MSB threads are very well balanced and very informative. Personally I'd like to say thanks to all who contribute to that.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.17
Change
-0.025(2.10%)
Mkt cap ! $1.324B
Open High Low Value Volume
$1.18 $1.22 $1.15 $4.288M 3.634M

Buyers (Bids)

No. Vol. Price($)
36 40452 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.17 88883 16
View Market Depth
Last trade - 13.52pm 15/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.